[Current aspects and prospects of the combined treatment of respiratory papillomatosis in children].
Treatment methods and outcomes have been analyzed for 313 children aged 9 months-14 years with respiratory papillomatosis (RP) admitted to ENT clinic in 1950-1995. Beginning from 1982 papillomas were removed by means of ultrasonic disintegration. A novel approach included extracorporeal detoxication and immunocorrection. 85% of patients responded to treatment with discrete plasmapheresis and T-activin. It is concluded that best treatment results were achieved in combination of conventional methods with advanced modalities such as extracorporeal detoxication and immunocorrection.
Zenger
V G
VG
Ashurov
Z M
ZM
Selin
V N
VN
Shevtsov
V V
VV
Vozhagov
V V
VV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000601:surgery / Q000628:therapy*; D053685:Laser Therapy; D010212:Papilloma / Q000601:surgery / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use; D010956:Plasmapheresis; D012121:Respiration, Artificial; D013949:Thymus Extracts / Q000627:therapeutic use; D014140:Tracheotomy; D014464:Ultrasonic Therapy
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Sovremennye aspekty i perspektivy kompleksnogo lecheniia respiratornogo papillomatoza u deteĭ.